We are currently restructuring our databases, so be advised that the FCPAC database is updated only through July 30, 2025.

Processing your request


please wait...

 | Investigations Dataset

Stanford Foreign Corrupt Practices Act Clearinghouse a Collaboration with Sullivan & Cromwell LLP

Investigations Dataset

 
Investigation into Johnson & Johnson's Brazilian Subsidiary's Activities in Brazil · Johnson & Johnson

Information & Summary

Investigation into Johnson & Johnson's Brazilian Subsidiary's Activities in Brazil

Related FCPA Matter:   Johnson & Johnson's Involvement in Brazil Information

Information & Summary

Investigation Name:    Investigation into Johnson & Johnson's Brazilian Subsidiary's Activities in Brazil

Trend:    None

Type of investigation:    SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:   

  • Brazilian Antitrust Authority CADE
  • Brazilian Public Prosecution Service in Rio de Janeiro

Whistleblower:    Unknown

Summary

Johnson & Johnson ("J&J") was a global pharmaceutical, consumer product, and medical device company headquartered in New Brunswick, NJ. Its securities were registered with the Commission, and its common stock traded on the New York Stock Exchange. J&J operated worldwide through more than 250 companies.

In its 10-Q filed on October 31, 2018, J&J disclosed that the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE had opened investigations into J&J's Brazilian subsidiary, Johnson & Johnson do Brasil Indústria e Comércio de Produtos para Saúde Ltda. ("J&J Brazil"), into allegations of possible anti-competitive behavior and possible improper payments in the medical device industry. As many as 30 other companies were also being investigated.

According to the same filing, the DOJ and SEC made preliminary inquiries about the Brazilian investigations, and J&J Brazil cooperated with those requests.

In its 10-Q filed on July 24, 2020, J&J confirmed that the inquires it had received from the DOJ and SEC were concerning the FCPA.

In its 10-K filed on February 13, 2025, J&J disclosed that the DOJ had informed the company that the agency had closed its investigation with no further action.

The SEC investigation is ongoing.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.